My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Nalco jumps 17.14% in six sessions
Mar 03,2017

The announcement was made after market hours yesterday, 2 March 2017.

The stock has jumped 17.14% to its current ruling price of Rs 75.85 in six sessions, from a close of Rs 64.75 on 22 February 2017.

Meanwhile, the S&P BSE Sensex was down 55.43 points or 0.19% at 28,784.36.

On the BSE, 4.73 lakh shares were traded in the counter so far as against average daily volume of 5.96 lakh shares in the past one quarter. The stock had hit a high of Rs 77.05 and a low of Rs 74.50 so far during the day. The stock had hit a 52-week high of Rs 79.35 on 27 January 2017. The stock had hit a 52-week low of Rs 32.95 on 2 March 2016.

It had underperformed the market over the past one month till 2 March 2017, gaining 2.03% compared with the Sensexs 2.17% rise. The scrip had, however, outperformed the market over the past one quarter, advancing 38.84% as against the Sensexs 9.95% rise.

The large-cap company has equity capital of Rs 966.46 crore. Face value per share is Rs 5.

Similarly, the hydrate production at its refinery has also registered an increase of 6.8%. The hydrate production till February 2017 was 18.9 lakh tonnes as against 17.7 lakh tonnes for the same period in the previous year. At its aluminium smelter, cast metal production grew by 3.79% and the aluminium metal sales grew by 2.68%.

Separately, the companys board of directors has approved payment of interim dividend of Rs 2.80 per share for the financial year ending 31 March 2017. The announcement was made after market hours yesterday, 2 March 2017.

Meanwhile, as per recent reports, China had ordered aluminium and steel producers in 28 cities to slash output during winter, as Beijing intensifies its war on smog.

Nalcos net profit fell 2.7% to Rs 143.92 crore on 13.9% rise in net sales Rs 1963.81 crore in Q3 December 2016 over Q3 December 2015.

State-run National Aluminium Company (Nalco) has integrated and diversified operations in mining, metal and power. The Government of India (GoI) held 74.58% stake in the company (as per the shareholding pattern as on 31 December 2016).

Powered by Capital Market - Live News

Increasing Insurance Coverage to Drive Growth of Corporate Healthcare Sector
Mar 03,2017

India Ratings and Research (Ind-Ra) has maintained a stable outlook for the corporate healthcare sector for FY18, based on expectations of continued stable revenue growth. Profit margins will continue to be impacted by expansion plans across the sector owing to long breakeven periods for new facilities.

Ind-Ra expects the sector to register stable revenue growth of about 15% for FY18, driven by the completion of new facilities and aided by strong growth in health insurance coverage. The growth in health insurance coverage (28.9% CAGR over FY14-FY16) is positive for the sector, as it increases the addressable market size. However, the majority of this growth was from government schemes; this is a concern due to lower profitability on procedures covered by such schemes and longer collection periods involved.

EBITDA margins and cash flow margins of companies operating in the sector will remain under pressure due to initial losses or lower profitability during the ramp-up phase of new facilities. Free cash flow (FCF) will continue to be negative due to expansion plans across the sector over the next three years.

Ind-Ra believes that large corporate hospital chains would attract patients to their facilities (old and new) on account of their established brands and ability to attract reputed doctors. Hence, the sector will continue to witness significant interest from private equity and strategic foreign investors, looking at leveraging the established brands of regional or sub-regional players to create strong national or regional chains. Ind-Ra believes that companies would increasingly rely on acquisitions to enter new cities, given the availability of capital.

OUTLOOK SENSITIVITIES

Positive FCF: Significant improvement in revenue and profits due to the successful ramp-up of new facilities, leading to positive FCF could result in a positive sector outlook.

Delay in Ramp-up: Ambitious debt-funded capex and stressed profitability due to low occupancy or cost and time overruns in ongoing capex could result in a negative outlook.

Powered by Capital Market - Live News

Apollo Hospitals Enterprise leads losers on BSEs A group
Mar 03,2017

Apollo Hospitals Enterprise shed 4.48% to Rs 1,257 on reports of stake sale by a Malaysian sovereign fund. The stock topped the losers in A group. On the BSE, 6.38 lakh shares were traded on the counter so far as against the average daily volumes of 12,000 shares in the past two weeks.

Media reports suggested that Khazanah Berhads subsidiary Integrated (Mauritius) Healthcare Holdings offloaded shares of Apollo Hospitals Enterprise through block deals on the stock exchanges today, 3 March 2017. Integrated (Mauritius) Healthcare Holdings owned 10.85% stake in Apollo Hospitals Enterprise end December 2016.

Jain Irrigation Systems fell 3.3% at Rs 89.30. The stock was the second biggest loser in A group. On the BSE, 3.4 lakh shares were traded on the counter so far as against the average daily volumes of 3.03 lakh shares in the past two weeks.

Amtek Auto fell 3.05% at Rs 36.50. The stock was the third biggest loser in A group. On the BSE, 2.4 lakh shares were traded on the counter so far as against the average daily volumes of 7.55 lakh shares in the past two weeks.

NCC declined 2.84% at Rs 78.70. The stock was the fourth biggest loser in A group. On the BSE, 2.4 lakh shares were traded on the counter so far as against the average daily volumes of 7.55 lakh shares in the past two weeks.

Bajaj Finserv dropped 2.7% at Rs 3,783.15. The stock was the fifth biggest loser in A group. On the BSE, 7,239 shares were traded on the counter so far as against the average daily volumes of 18,000 shares in the past two weeks.

Powered by Capital Market - Live News

Volumes jump at Geometric counter
Mar 03,2017

Geometric clocked volume of 10.15 lakh shares by 13:46 IST on BSE, a 132.51-times surge over two-week average daily volume of 8,000 shares. The stock was up 0.75% at Rs 262.75.

Apollo Hospitals Enterprise notched up volume of 6.37 lakh shares, a 52.55-fold surge over two-week average daily volume of 12,000 shares. The stock was down 4.51% at Rs 1,256.50.

Vista Pharmaceuticals saw volume of 25.74 lakh shares, a 24.34-fold surge over two-week average daily volume of 1.06 lakh shares. The stock surged by its upper circuit limit of 20% at Rs 30.90.

Dhampur Sugar Mills clocked volume of 3.34 lakh shares, a 5.52-fold surge over two-week average daily volume of 60,000 shares. The stock jumped 10.53% at Rs 205.75.

Dwarikesh Sugar Industries saw volume of 2.29 lakh shares, a 5.35-fold rise over two-week average daily volume of 43,000 shares. The stock was up 7.48% at Rs 427.50.

Powered by Capital Market - Live News

PTC India announces cessation of nominee director
Mar 03,2017

PTC India announced that Jayant Kumar, Nominee Director of NHPC (DIN - 03010235), has ceased to be a Director on the Board of PTC India w.e.f 01-03-2017 consequent upon his superannuation from NHPC.

Powered by Capital Market - Live News

Board of Southern Online Bio Technologies decides to shut down subsidiary in UAE
Mar 03,2017

The Board of Directors of the Southern Online Bio Technologies in its meeting held on 3 March 2017 inter alia has decided to shut down its operations of Marvel Bio Oil FZE, Sharjah, UAE, a 100% subsidiary of the company.

Powered by Capital Market - Live News

Apollo Hospitals drops on reports of stake-sale by a foreign fund
Mar 03,2017

Meanwhile, the S&P BSE Sensex was down 85 points or 0.29% at 28,754.79.

On the BSE, 6.10 lakh shares were traded on the counter so far as against the average daily volumes of 9,335 shares in the past one quarter. The stock had hit a high of Rs 1,288 and a low of Rs 1,246 so far during the day.

The stock had hit a record high of Rs 1,544 on 2 March 2016 and a 52-week low of Rs 1,110.75 on 26 December 2016. It had outperformed the market over the past one month till 2 March 2017, gaining 6.88% compared with the Sensexs 2.17% rise. The scrip had, however, underperformed the market over the past one quarter, advancing 9.65% as against the Sensexs 9.95% rise.

The large-cap company has equity capital of Rs 69.56 crore. Face value per share is Rs 5.

Media reports suggested that Khazanah Berhads subsidiary Integrated (Mauritius) Healthcare Holdings offloaded shares of Apollo Hospitals Enterprise through block deals on the stock exchanges today, 3 March 2017. Integrated (Mauritius) Healthcare Holdings owned 10.85% stake in Apollo Hospitals Enterprise end December 2016.

Apollo Hospitals net profit fell 40.5% to Rs 72.83 crore on 17.9% growth in net sales to Rs 1680.61 crore in Q3 December 2016 over Q3 December 2015.

Apollo Hospitals is one of Asias largest healthcare groups.

Powered by Capital Market - Live News

Excel Crop Care gets revision in credit ratings for bank facilities
Mar 03,2017

Excel Crop Care announced that CRISIL has upgraded its Long Term Rating in relation to the Companys Bank Facilities aggregating Rs. 200 crore from existing CRISIL A+/Positive to CRISIL AA-/Stable.

The short term rating in relation to the said bank facilities continue to be CRISIL A1+.

Powered by Capital Market - Live News

Dhanlaxmi Bank announces cessation of director
Mar 03,2017

Dhanlaxmi Bank announced that the term of office of Susobhan Sinha, who was nominated by RBI to the Board as an Additional Director with effect from 02 March 2015, has come to an end on 01 March 2017

Powered by Capital Market - Live News

Equitas Holdings intimates ratings assigned for Deposits programme of subsidiary
Mar 03,2017

Equitas Holdings announced that CRISIL has assigned CRISIL A1+ (pronounced as CRISIL A one plus) rating on Rs. 1000 crore Certificate of Deposits Programme of the Subsidiary Company, Equitas Small Finance Bank.

Powered by Capital Market - Live News

Lupin gains after receiving final approval from USFDA for generic drug
Mar 03,2017

The announcement was made during market hours today, 3 March 2017.

Meanwhile, the S&P BSE Sensex was down 80.85 points or 0.29% at 28,757.38.

On the BSE, 10,780 shares were traded on the counter so far as against the average daily volumes of 72,224 shares in the past one quarter. The stock had hit a high of Rs 1,472 and a low of Rs 1,456.15 so far during the day.

The stock had hit a 52-week high of Rs 1,874.30 on 14 March 2016 and a 52-week low of Rs 1,294.05 on 29 March 2016. The stock had underperformed the market over the past one month till 2 March 2017, falling 1.52% compared with the Sensexs 2.17% rise. The scrip had also underperformed the market over the past one quarter, falling 1.86% as against the Sensexs 9.95% rise.

The large-cap company has equity capital of Rs 90.31 crore. Face value per share is Rs 2.

Lupin announced that it has received final approval for its Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces from the United States Food & Drug Administration (USFDA) to market a generic version of Braintree Laboratories Suprep Bowel Prep Kit.

Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g is indicated for the cleansing of the colon in preparation for colonoscopy in adults. Suprep Bowel Prep Kit had annual US sales of $207.20 million as per IMS MAT December 2016 data.

Lupins consolidated net profit rose 20.7% to Rs 633.11 crore on 31.5% increase in net sales to Rs 4404.94 crore in Q3 December 2016 over Q3 December 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective and NSAID space and holds global leadership position in the anti-TB segment.

Powered by Capital Market - Live News

Balkrishna Industries drops on profit booking
Mar 03,2017

Meanwhile, the S&P BSE Sensex was down 85.51 points, 0.3% to Rs 28,754.28.

On the BSE, 4,647 shares were traded on the counter so far as against the average daily volumes of 12,004 shares in the past one quarter. The stock had hit a high of Rs 1,354.65 and a low of Rs 1,307.85 so far during the day.

The stock had hit a record high of Rs 1,398 on 2 March 2017 and a 52-week low of Rs 572.90 on 2 March 2016. The stock had outperformed the market over the past one month till 2 March 2017, advancing 17.28% compared with the Sensexs 2.17% rise. The scrip had also outperformed the market over the past one quarter advancing 10.16% as against the Sensexs 9.95% rise.

The large-cap company has equity capital of Rs 19.33 crore. Face value per share is Rs 2.

Shares of Balkrishna Industries had rallied 16.49% in the preceding eight trading session to settle at Rs 1,342.05 yesterday, 2 March 2017, from its close of Rs 1,152 on 17 February 2017.

Balkrishna Industries net profit rose 94.2% to Rs 185.69 crore on 25.7% increase in net sales to Rs 864.69 crore in Q3 December 2016 over Q3 December 2015.

Balkrishna Industries is a leading manufacturer in the off-highway tire market. The company has focused on specialist segments such as agricultural, construction and industrial vehicles as well as earthmoving, port and mining, ATV, and gardening applications.

Powered by Capital Market - Live News

Syngene International gains after entering into partnership with Herbalife Nutrition
Mar 03,2017

The announcement was made after market hours yesterday, 2 March 2017.

Meanwhile, the S&P BSE Sensex was down 77.09 points, 0.27% to Rs 28,762.70.

On the BSE, 18,000 shares were traded on the counter so far as against the average daily volumes of 40,750 shares in the past one quarter. The stock had hit a high of Rs 504.40 and a low of Rs 487 so far during the day.

The stock had hit a 52-week high of Rs 663.30 on 9 December 2016 and a 52-week low of Rs 349 on 5 April 2016. The stock had underperformed the market over the past one month till 2 March 2017, declining 10.18% compared with the Sensexs 2.17% rise. The scrip had also underperformed the market over the past one quarter declining 14.86% as against the Sensexs 9.95% rise.

The mid-cap company has equity capital of Rs 200 crore. Face value per share is Rs 10.

Herbalife a global nutrition company, yesterday, 2 March 2017 announced the launch of its first nutrition research and development Lab in India, in partnership with Syngene. The strategic partnership will help Herbalife Nutrition develop and formulate world-class nutrition products for Indian consumers.

The new nutrition research and development facility spans 3,000 square feet, and is located within the Syngene campus at Bangalore. The facility also houses a separate good manufacturing practices (GMP) formulation lab to support product testing, sampling and end-product development.

Ajay Khanna,Vice President and Country Head, Herbalife International India said, practicing good nutrition habits is fast becoming a way of life and it is imperative for the company to ensure that it consistently deliver high quality and affordable products to our consumers.

Dr. Kiran Mazumdar Shaw, Managing Director, Syngene International said, the company is happy to partner with Herbalife in setting up their nutrition research and development Lab.

Syngene Internationals net profit rose 11.54% to Rs 74.40 crore on 17.7% increase in net sales to Rs 323.80 crore in Q3 December 2016 over Q3 December 2015.

Promoted by Biocon, Syngene International is one of Asias largest contract research organizations. The company provides discovery, development and manufacturing services across life-science based industries.

Powered by Capital Market - Live News

New order boosts A2Z Infra Engineering
Mar 03,2017

The announcement was made after market hours yesterday, 2 March 2017.

Meanwhile, the S&P BSE Sensex was down 76.14 points or 0.26% at 28,763.65.

On the BSE, 2.27 lakh shares were traded on the counter so far as against the average daily volumes of 1.93 lakh shares in the past one quarter. The stock had hit a high of Rs 42.45 and a low of Rs 41.30 so far during the day.

The stock had hit a 52-week high of Rs 51.65 on 1 November 2016 and a 52-week low of Rs 19 on 1 April 2016. It had underperformed the market over the past one month till 2 March 2017, sliding 6.79% compared with the Sensexs 2.17% rise. The scrip had also underperformed the market over the past one quarter, advancing 0.63% as against the Sensexs 9.95% rise.

The small-cap company has equity capital of Rs 131.01 crore. Face value per share is Rs 10.

A2Z Infra Engineering said it has been awarded a contract worth $7.06 million from Grid Solar and Energy Efficiency Project, Nepal Electricity Authority for design, supply, delivery, installation, testing and commissioning of substations and lines.

A2Z Infra Engineering reported a net loss of Rs 24.06 crore in Q3 December 2016, higher than net loss of Rs 3.41 crore in Q3 December 2015. Net sales declined 58.1% to Rs 112.38 crore in Q3 December 2016 over Q3 December 2015.

A2Z Infra Engineering (formerly known as A2Z Maintenance & Engineering Services) is a fast growing, fully integrated electrical business group (EBG) in India catering to the needs of domestic and international power sector clients in building distribution and transmission infrastructure.

Powered by Capital Market - Live News

Tayo Rolls to allots 2 lakh preference shares to Tata Steel
Mar 03,2017

Tayo Rolls announced that the Committee of the Board of Directors at its meeting held on 03 March 2017 has decided to allot 2 lakh 7.17% Non Cumulative Redeemable Preference Shares of Rs 100 each aggregating to Rs 2 crore to Tata Steel, the Promoter on preferential basis.

Powered by Capital Market - Live News